Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$13 Mln
P/E Ratio
--
P/B Ratio
0.76
Industry P/E
36.75
Debt to Equity
0
ROE
-2.69 %
ROCE
--
Div. Yield
0 %
Book Value
--
EPS
--
CFO
$-11.37 Mln
EBITDA
$-17.33 Mln
Net Profit
$-34.83 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Trxade Group Inc (MEDS)
| 55.89 | 20.18 | -2.41 | 43.11 | -47.25 | -41.82 | -25.68 |
|
BSE Sensex*
| 2.05 | 3.83 | 4.35 | 8.29 | 11.76 | 20.17 | 11.15 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2023
|
2022
|
2021
|
2020
|
2017
|
|
|---|---|---|---|---|---|
|
Trxade Group Inc (MEDS)
| -13.96 | -82.92 | -55.39 | -19.85 | -2.16 |
|
S&P Small-Cap 600
| 13.89 | -17.42 | 25.27 | 9.57 | 11.73 |
|
BSE Sensex
| 18.74 | 4.44 | 21.99 | 15.75 | 27.91 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 63.14 | 3,494.54 | -- | -33091.46 |
TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations,... hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida. Read more
Founder, Chairman, CEO & Secretary
Mr. Surendra K. Ajjarapu
Founder, Chairman, CEO & Secretary
Mr. Surendra K. Ajjarapu
Headquarters
Tampa, FL
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Trxade Group Inc (MEDS) stood at $ 18 Mln as on 30-Jun-24
The share price of Trxade Group Inc (MEDS) is $7.54 (NASDAQ) as of 21-Nov-2024 09:30 EDT. Trxade Group Inc (MEDS) has given a return of -47.25% in the last 3 years.
Trxade Group Inc (MEDS) has a market capitalisation of $ 13 Mln as on 22-Nov-2024. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Trxade Group Inc (MEDS) is 0.76 times as on 22-Nov-2024, a 86% discount to its peers’ median range of 5.49 times.
Since, TTM earnings of Trxade Group Inc (MEDS) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Trxade Group Inc (MEDS) and enter the required number of quantities and click on buy to purchase the shares of Trxade Group Inc (MEDS).
TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.
The CEO & director of Mr. Surendra K. Ajjarapu. is Trxade Group Inc (MEDS), and CFO & Sr. VP is Mr. Surendra K. Ajjarapu.
There is no promoter pledging in Trxade Group Inc (MEDS).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
349
|
| Trxade Group Inc (MEDS) | Ratios |
|---|---|
|
Return on equity(%)
|
-148.42
|
|
Operating margin(%)
|
-117.62
|
|
Net Margin(%)
|
-267.05
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Trxade Group Inc (MEDS) was $0 Mln.
$-0.56
(
